Japan updates its lung cancer screening guideline for the first time in 19 years: who should have a low-dose CT

Health checkups

Japan's National Cancer Center updated its lung cancer screening guideline in 2025. Yearly low-dose CT for heavy smokers gets the top recommendation; for others the evidence is not yet enough to recommend it as public screening.

Why it matters

About 120,000 people in Japan are diagnosed with lung cancer each year, the second most common cancer, and about 75,000 die of it, more than from any other cancer. Many clients booking a checkup in Japan ask whether they should have a chest CT.

On 25 April 2025 the National Cancer Center published the 2025 edition of its evidence-based lung cancer screening guideline, the first update since the 2006 edition.

What the guideline says

  • Heavy smokers (a smoking index of 600 or more, that is cigarettes a day × years ≥ 600, including people who quit less than 15 years ago): low-dose CT once a year from age 50 to 74, grade A, recommended both for public screening and for self-pay checkups.
  • Others: the evidence that low-dose CT reduces lung cancer deaths is insufficient, grade I, and it is not recommended as public screening. In self-pay checkups, a health professional should explain the benefits and harms so that the person can decide.
  • Chest X-ray: grade A.

The downsides of low-dose CT

The guideline highlights two harms: overdiagnosis, where screening finds changes that would never have caused harm and leads to tests and treatment that were not needed, and radiation exposure. False positives also bring further tests and the worry of waiting for results.

Choosing at a checkup in Japan

Comprehensive checkups in Japan often include a low-dose chest CT as standard. For heavy smokers and recent quitters, the guideline supports a yearly scan. If you do not smoke, ask the physician to weigh the benefits and harms against your age, family history and earlier results before deciding whether and how often to have one.

Researchers point out that lung cancer in non-smokers is more common in Asia than in Europe and the United States, and Japanese experts continue to discuss what screening suits the country.

Tell us about your situation

The first consultation is free. Tell us what you are interested in, what you have had done before and when you would like to come. We reply within two business days.

Contact us